News & Events about Novavax Inc.
Novavax Announces Initiation of Phase 2 Trial for COVID-19-Influenza Combination and Stand-Alone Influenza Vaccine Candidates Novavax Announces Initiation of Phase 2 Trial for COVID-19-Influenza Combination and Stand-Alone Influenza Vaccine Candidates PR Newswire GAITHERSBURG, Md., Dec. 30, 2022...
CNW Group - News Releases
1month ago
Novavax Announces Pricing of $150 Million Offering of Convertible Senior Notes Novavax Announces Pricing of $150 Million Offering of Convertible Senior Notes Canada NewsWire GAITHERSBURG, Md., Dec. 15, 2022 GAITHERSBURG, Md., Dec. 15, 2022 /CNW/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology...
CNW Group - News Releases
1month ago
Novavax Announces Pricing of $65 Million Public Offering of Common Stock Novavax Announces Pricing of $65 Million Public Offering of Common Stock Canada NewsWire GAITHERSBURG, Md., Dec. 15, 2022 GAITHERSBURG, Md., Dec. 15, 2022 /CNW/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company...
Novavax Announces Pricing of $65 Million Public Offering of Common Stock Novavax Announces Pricing of $65 Million Public Offering of Common Stock PR Newswire GAITHERSBURG, Md., Dec. 15, 2022 GAITHERSBURG, Md., Dec. 15, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company...